Identifying and assessing potential harm of medication errors and potentially unsafe medication practices in

Rikke Mie Rishoej1, Anna Birna Almarsdóttir2, Henrik Thybo Christesen3

  • 1Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, JB Winsløws Vej 19, 2, Odense C, Funen 5000, Denmark.

Insights

Medication errors and unsafe practices were observed in hospitalized children, but no actual harm occurred. Rater agreement on potential harm was low, indicating a need for better error assessment methods.

Area of Science:

  • Pediatric patient safety
  • Medication safety research
  • Healthcare quality improvement

Background:

  • Hospitalized children face risks from medication errors (MEs).
  • Identifying process failures is key to preventing MEs.
  • This study focused on MEs and potentially unsafe medication practices (PUMPs) in pediatric inpatients.

Purpose of the Study:

  • To identify MEs and PUMPs in hospitalized children.
  • To assess the potential harm of identified errors and practices.
  • To evaluate inter-rater agreement on harm assessment.

Main Methods:

  • One-week observational study on four pediatric wards.
  • Documentation of MEs and PUMPs during prescribing, preparation, and administration.
  • Harm assessment by a physician, nurse, and clinical pharmacist using a Likert scale.

Main Results:

  • 16 MEs and 809 PUMPs identified; 8% error rate in preparation/administration.
  • No actual patient harm observed.
  • Low inter-rater agreement (Kappa = 0.26-0.33) on potential harm; highest score for delayed cefuroxime administration.

Conclusions:

  • MEs and unsafe practices pose risks to hospitalized children's medication safety.
  • Observed MEs did not lead to patient harm.
  • Low rater agreement necessitates alternative methods for determining clinical relevance of errors.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
246
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
803
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
259
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
217
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
361
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330